homeostasis/metabolism
• increased levels of serum proinflammatory cytokines (including Tnf and Il1b) after i.p. injection with interleukin 1 beta or L. monocytogenes
|
immune system
• increased levels of serum proinflammatory cytokines (including Tnf and Il1b) after i.p. injection with interleukin 1 beta or L. monocytogenes
|
• reduced levels of L. monocytogenes in spleen and liver compared to wild-type littermates at 2 d post-i.p. injection with L. monocytogenes
• increased inflammatory damage to lungs and small intestinal villi after i.p. injection with L. monocytogenes
• increased lethality after i.p. injection with L. monocytogenes
|
mortality/aging
• reduced levels of L. monocytogenes in spleen and liver compared to wild-type littermates at 2 d post-i.p. injection with L. monocytogenes
• increased inflammatory damage to lungs and small intestinal villi after i.p. injection with L. monocytogenes
• increased lethality after i.p. injection with L. monocytogenes
|
• increased lethality after i.p. injection with interleukin 1 beta plus D-galactosamine
• earlier onset of lethality after i.p. injection with interleukin 1 beta plus D-galactosamine
|